comparemela.com

Latest Breaking News On - Daniel mangless - Page 1 : comparemela.com

Zevra Therapeutics Files Definitive Proxy Statement and

Urges Shareholders to Vote "FOR" All Zevra Director Nominees on the WHITE Proxy Card CELEBRATION, Fla., March 15, 2023 (GLOBE NEWSWIRE) Zevra.

Richardw pascoeChristophera posnerJoele frankNichol ochsnerJennifer arcureDaniel manglessDavids tierneyWilkinson brimmer katcherMatthewr ploosterZevra therapeutics incCompany early access programDrug administrationEarly access programUs drug enforcement agencyExchange commissionCompany board

Zevra Therapeutics, a Rare Disease Therapeutics Company,

CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (“Zevra” or the “Company” and formerly known as KemPharm,.

Richardw pascoeChristophera posnerJoele frankNichol ochsnerJennifer arcureDaniel manglessDavids tierneyTravisc mickleWilkinson brimmer katcherMatthewr ploosterZevra therapeutics incCompany early access programCorium incDrug administrationUs drug enforcement agencyCompany annual meeting

vimarsana © 2020. All Rights Reserved.